Fig. 6From: Urinary exosome proteins PAK6 and EGFR as noninvasive diagnostic biomarkers of diabetic nephropathyROC curve analysis of urinary exosome proteins PAK6 and EGFR. Discovery phase: (A) PAK6, (B) EGFR, and (C) the combination of PAK6 and EGFR. Validation phase: (D) PAK6, (E) EGFR, and (F) the combination of PAK6 and EGFR. AUC: area under curve; 95% CI: 95% confidence intervalBack to article page